Gender and bladder cancer: a collaborative review of etiology, biology, and outcomes

J Dobruch, S Daneshmand, M Fisch, Y Lotan, AP Noon… - European urology, 2016 - Elsevier
Context The incidence of bladder cancer is three to four times greater in men than in women.
However, women are diagnosed with more advanced disease at presentation and have less …

The role of tobacco smoke in bladder and kidney carcinogenesis: a comparison of exposures and meta-analysis of incidence and mortality risks

MG Cumberbatch, M Rota, JWF Catto, C La Vecchia - European urology, 2016 - Elsevier
Context Tobacco smoke includes a mix of carcinogens implicated in the etiology of bladder
cancer (BC) and renal cell cancer (RCC). Objective We reviewed the impact of tobacco …

[HTML][HTML] A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: final overall survival results and …

CN Sternberg, RE Hawkins, J Wagstaff… - European journal of …, 2013 - Elsevier
BACKGROUND: In this randomised phase III study (VEG105192; NCT00334282),
pazopanib previously demonstrated statistically and clinically meaningful improvement of …

Smoking and all-cause mortality in older people: systematic review and meta-analysis

C Gellert, B Schöttker, H Brenner - Archives of internal medicine, 2012 - jamanetwork.com
Background Smoking is an established risk factor of premature death. However, most
pertinent studies primarily relied on middle-aged adults. We performed a systematic review …

Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapy

JS Ross, K Wang, RN Al-Rohil, T Nazeer… - Modern …, 2014 - nature.com
Although urothelial carcinoma (UC) of the urinary bladder generally portends a favorable
prognosis, metastatic tumors often follow an aggressive clinical course. DNA was extracted …

Bladder cancer risk from occupational and environmental exposures

KJ Kiriluk, SM Prasad, AR Patel, GD Steinberg… - … Oncology: Seminars and …, 2012 - Elsevier
Approximately 50% of bladder cancer incidence in the United States has been attributed to
known carcinogens, mainly from cigarette smoking. Following the identification of this …

Smoking and bladder cancer: a systematic review of risk and outcomes

M Rink, JJ Crivelli, SF Shariat, FK Chun… - European urology …, 2015 - Elsevier
Context Cigarette smoking is an established risk factor for urothelial carcinoma. Objective To
elucidate the association between pretreatment smoking status, cumulative exposure, and …

Impact of smoking and smoking cessation on oncologic outcomes in primary non–muscle-invasive bladder cancer

M Rink, H Furberg, EC Zabor, E Xylinas, M Babjuk… - European urology, 2013 - Elsevier
BACKGROUND: Cigarette smoking is the best-established risk factor for urothelial
carcinoma (UC) development, but the impact on oncologic outcomes remains poorly …

Smoking status is a risk factor for recurrence after transurethral resection of non–muscle-invasive bladder cancer

RJM Lammers, WPJ Witjes, K Hendricksen, CTM Caris… - European urology, 2011 - Elsevier
BACKGROUND: Cigarette smoking is the most well-established risk factor for developing
bladder cancer. OBJECTIVE: To investigate the role of smoking status on the clinical …

Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy

M Rink, EC Zabor, H Furberg, E Xylinas, B Ehdaie… - European urology, 2013 - Elsevier
Background Cigarette smoking is the best-established risk factor for urothelial carcinoma
development. Objective To elucidate the association of pretreatment smoking status …